Balaña, C., Capellades Font, J., Martínez-García, M., Alameda Quitllet, F., & Group, G. (2017). Pseudoprogression as an adverse event of glioblastoma therapy.
Citación estilo ChicagoBalaña, Carmen, Jaume Capellades Font, Maria Martínez-García, Francisco Alameda Quitllet, y GLIOCAT Group. Pseudoprogression As an Adverse Event of Glioblastoma Therapy. 2017.
Cita MLABalaña, Carmen, et al. Pseudoprogression As an Adverse Event of Glioblastoma Therapy. 2017.
Precaución: Estas citas no son 100% exactas.